MBA Alumni | MBA Students | MBA Aspirants | MBA Forums
--- MBA Home ---

CoolAvenues.com

offers
Advertising
Services

on the web  
 

Home     |    MBA Jobs      |     Knowledge Zone      |     Seminars      |     Placement Report      |     Admission Alert       |     café     |     Search

Corporate Strategy | "How India & Indian Corporate Can Tap Emerging Global Healthcare Market"

General Management @ Knowledge Zone

 Home

 Knowledge Zone Home

 General Management

 Finance

 Marketing

 Human Resource

 System

 Operations

 Knowledge Seminar

 MBA Forums
 Search
 Join e-Communities
 Be a CoolAssociate
 Give Suggestions

 Company Search
 
 

Subscribe:
Seminar & MDP Alert
   To keep yourself updated with the latest Seminars & MDP happenings in the country, join Knowledge Seminar& MDP mailing lists.


Latest Management Discussion on CoolAvenues Forums



How India & Indian Corporate Can Tap Emerging Global Healthcare Market

- by Jyoti Singh & Sugandha Bhandari *

Previous

Page - 8

4. Increasing Accessibility

  • Pharmacy Chains
         * Pharmacy chains are appearing in S. E. Asia especially in India.
         * The advantage of pharmacy chains is primarily the increased accessibility to new markets.

  • Hospitals on Wheels
         * State-of-the-art ultra-sound, X-ray Machine CG 202.
         * Computerized lab and three channels ECG machine available on road equipped to impart health education through audio visual facilities.

  • 5. Comparative Advantages

    Open-Heart Surgery - Open-Heart Surgery in the UK can cost more than $20,000 and double that in the United States. In India, leading hospitals can perform that surgery for less than $5,000.

    US ($) India ($)
      Bone Marrow Transplant   400,000   30,000
      Liver Transplant   500,000   40,000
      Open Heart Surgery (CABG)   50,000   4,400
      Neuro Surgery   29,000   8000
      Knee Surgery   16,000   4,500

    Competitive advantage would go to firms that best control clinical trial costs, which alone account for a third of the total cost of drug development and almost half the time taken. Most Indian pharma majors are meeting this challenge by conducting clinical trials for their drugs indigenously.

    6. Response Generation through Promotion

    FMRAI has been consistent in its approach towards ethical sales promotion and come out with a model sales promotion policy to be followed by every pharmaceutical company of India. FMRAI members were the first to point out the illegal clinical trials carried out by Sun Pharmaceuticals for their Letrozole brand and personnel attached to Sun Pharma were thrown out of their jobs.

    Next


    * Contributed by: -
    Jyoti Singh & Sugandha Bhandari,
    PGDBM 2006,
    IMT, Ghaziabad.


    Post Your Comments       |       E-mail to Friend       |       Want to Contribute

    Send this E-mail this Article

     

    MBA Jobs
    MBA Preparation
    B-Schools
    MBA Forums
    About CoolAvenues
    Senior Mgmt Jobs CAT / MAT/ CET Dean talk CAT Preparation Post a Job
    Finance Jobs Admission Alert B-School Profile Executive MBA Advertise with Us
    Marketing Jobs MBA Insider B-School Diary Career Help Contact us
    HR MBA Jobs MBA Admission Process Summer GMAT Privacy
    Operations MBA Jobs English Preparation MBA News Companies Copyrights
    IT MBA Jobs MBA Abroad MBA Events B-Schools About CoolAenues
    Consulting MBA Jobs CAT / MAT / CET test papers MBA Placements Summer Guidance
    Resume Design Tips MBA in India Summers Guide Classifieds

    © All Copyrights exclusive with Zebra Networks
    Part or full of the contents can not be published, copied or reproduced
    in any form without the prior written exclusive permission of Zebra Networks. Pls refer to CoolAvenues Copyright section.